From Awareness to Action: World Bipolar Day
March 30, 2026
World Bipolar Day is celebrated each year on March 30th. World Bipo...
Read More
Rethinking Mood Disorder Treatment with Immunometabolic Insights
March 17, 2026
While there are many stimulant and non-stimulant options targeting ...
Read More
FDA Approves Milsaperidone for Schizophrenia and Acute Bipolar I Disorder
February 20, 2026
The FDA has approved milsaperidone for the treatment of schizophren...
Read More
Antipsychotic Polypharmacy on the Rise
December 16, 2024
Antipsychotic polypharmacy remains a common practice despite eviden...
Read More
Valproate Use During Spermatogenesis and Risk to Offspring
June 28, 2024
While the teratogenic risks associated with maternal exposure to th...
Read More
Adolescent and Adult Transitions From Major Depressive Disorder to Bipolar Disorder
June 21, 2024
Bipolar disorder (BD) often appears after onset of major depressive...
Read More
Highlights from 2024 NEI Synapse: Don’t Get Mixed Up! Recognizing and Treating Mixed Features Across the Lifespan
April 20, 2024
One of the most overlooked and underdiagnosed manifestations along ...
Read More
FDA Approves Treatment for Mixed, Manic Episodes Associated With Bipolar I Disorder
April 3, 2024
The FDA has expanded the approval iloperidone to include for the ac...
Read More
World Bipolar Day Is Celebrated Each Year On March 30th
March 30, 2024
World Bipolar Day is celebrated each year on March 30th. World Bipo...
Read More
Efficacy of Cariprazine in Patients with Bipolar Depression and Comorbid Anxiety
February 21, 2024
A recent post-hoc analysis suggest that cariprazine is a viable tre...
Read More
Bipolar Disorder and Cumulative Trauma
February 14, 2024
A recent review underscores the high prevalence and adverse impacts...
Read More
Liraglutide for Weight Loss in Stable Bipolar Disorder
February 2, 2024
An all-too-common comorbidity for those suffering with bipolar diso...
Read More